JPWO2021230131A1 - - Google Patents
Info
- Publication number
- JPWO2021230131A1 JPWO2021230131A1 JP2022521858A JP2022521858A JPWO2021230131A1 JP WO2021230131 A1 JPWO2021230131 A1 JP WO2021230131A1 JP 2022521858 A JP2022521858 A JP 2022521858A JP 2022521858 A JP2022521858 A JP 2022521858A JP WO2021230131 A1 JPWO2021230131 A1 JP WO2021230131A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024189461A JP2025010627A (ja) | 2020-05-11 | 2024-10-29 | 軽度認知障害治療剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020083163 | 2020-05-11 | ||
| JP2020083163 | 2020-05-11 | ||
| PCT/JP2021/017368 WO2021230131A1 (ja) | 2020-05-11 | 2021-05-06 | 軽度認知障害治療剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024189461A Division JP2025010627A (ja) | 2020-05-11 | 2024-10-29 | 軽度認知障害治療剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021230131A1 true JPWO2021230131A1 (https=) | 2021-11-18 |
| JPWO2021230131A5 JPWO2021230131A5 (https=) | 2023-04-12 |
| JP7587218B2 JP7587218B2 (ja) | 2024-11-20 |
Family
ID=78525720
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521858A Active JP7587218B2 (ja) | 2020-05-11 | 2021-05-06 | 軽度認知障害治療剤 |
| JP2024189461A Pending JP2025010627A (ja) | 2020-05-11 | 2024-10-29 | 軽度認知障害治療剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024189461A Pending JP2025010627A (ja) | 2020-05-11 | 2024-10-29 | 軽度認知障害治療剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230270737A1 (https=) |
| EP (1) | EP4151213A4 (https=) |
| JP (2) | JP7587218B2 (https=) |
| CN (1) | CN115551508A (https=) |
| WO (1) | WO2021230131A1 (https=) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013187075A1 (ja) * | 2012-06-15 | 2013-12-19 | 公益財団法人先端医療振興財団 | 軽度認知障害の予防および／または治療剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI323660B (en) * | 2003-02-25 | 2010-04-21 | Otsuka Pharma Co Ltd | Pten inhibitor or maxi-k channels opener |
| WO2009133128A1 (en) * | 2008-04-29 | 2009-11-05 | Pharnext | Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate |
| KR20120010800A (ko) * | 2010-07-27 | 2012-02-06 | 인제대학교 산학협력단 | 실로스타졸 또는 이의 약리학적 허용가능한 염을 유효성분으로 함유하는 퇴행성 신경질환 치료 및 예방용 약학조성물 |
| CN108430474A (zh) * | 2015-12-25 | 2018-08-21 | 大塚制药株式会社 | 包含阿立哌唑和西洛他唑的药物 |
-
2021
- 2021-05-06 WO PCT/JP2021/017368 patent/WO2021230131A1/ja not_active Ceased
- 2021-05-06 EP EP21805235.5A patent/EP4151213A4/en active Pending
- 2021-05-06 JP JP2022521858A patent/JP7587218B2/ja active Active
- 2021-05-06 CN CN202180034439.4A patent/CN115551508A/zh active Pending
- 2021-05-06 US US17/924,447 patent/US20230270737A1/en active Pending
-
2024
- 2024-10-29 JP JP2024189461A patent/JP2025010627A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013187075A1 (ja) * | 2012-06-15 | 2013-12-19 | 公益財団法人先端医療振興財団 | 軽度認知障害の予防および／または治療剤 |
Non-Patent Citations (3)
| Title |
|---|
| FU, C.H. J., ET AL., JOURNAL OF CHROMATOGRAPHY B: BIOMEDICAL SCIENCES AND APPLICATIONS, vol. 728, no. 2, JPN6021025458, 1999, pages 251 - 262, ISSN: 0005340604 * |
| LIU, Y., ET AL., CARDIOVASCULAR DRUG REVIEWS, vol. 19, no. 4, JPN6021025455, 2001, pages 369 - 386, ISSN: 0005340603 * |
| MAKI, T., ET AL., ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, vol. 1, no. 8, JPN6021025452, 2014, pages 519 - 533, ISSN: 0005340602 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115551508A (zh) | 2022-12-30 |
| US20230270737A1 (en) | 2023-08-31 |
| WO2021230131A1 (ja) | 2021-11-18 |
| JP7587218B2 (ja) | 2024-11-20 |
| EP4151213A4 (en) | 2024-05-29 |
| EP4151213A1 (en) | 2023-03-22 |
| JP2025010627A (ja) | 2025-01-22 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221107 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221107 |
|
| AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20230119 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230307 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231004 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231130 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240202 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240605 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240711 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240930 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20241028 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7587218 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |